Literature DB >> 15683227

In the quest for stable rescuing mutants of p53: computational mutagenesis of flexible loop L1.

Yongping Pan1, Buyong Ma, R Babu Venkataraghavan, Arnold J Levine, Ruth Nussinov.   

Abstract

p53 is a protein with marginal stability. Its transcriptional functions are often inactivated by single missense mutations, shown to be associated with half of all human cancers. Here, we aim to design stable functional p53 mutants. We target loop L1, one of the most mobile structural motifs in the p53 core domain (p53C). Specifically, we selected Ser116 in the middle of loop L1 and mutated it to 14 other amino acids. All resulting mutants were subjected to molecular dynamics simulations, revealing a wide spectrum of stabilities. Among these, mutant S116M displayed a remarkable stability, with a structural deviation comparable to that of the experimental quadruple mutant M133L/V203A/N239Y/N268D that is thermodynamically more stable than that of the wild type by 2.6 kcal/mol. Structural analysis showed that the high stability of the S116M mutant was indeed due to the preservation of the p53C loop L1 conformation and the reduction of mobility in that region. The differential stabilities conferred by the single mutations are rationalized based on the geometries and chemical properties of the side chains introduced into this site. Linearity (i.e., nonbranched), moderate size, and balanced hydrophobic and hydrophilic properties of the side chain are crucial to the stabilizing effect of the residue substitutions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683227     DOI: 10.1021/bi047845y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Effects of serine-to-cysteine mutations on beta-lactamase folding.

Authors:  Javier Santos; Valeria A Risso; Mauricio P Sica; Mario R Ermácora
Journal:  Biophys J       Date:  2007-05-11       Impact factor: 4.033

2.  TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection.

Authors:  Apostolos Klinakis; Theodoros Rampias
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

3.  Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design.

Authors:  Jin Liu; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

4.  Molecular mechanisms of functional rescue mediated by P53 tumor suppressor mutations.

Authors:  Yu-Hong Tan; Y Morris Chen; Xiang Ye; Qiang Lu; Vira Tretyachenko-Ladokhina; Wei Yang; Donald F Senear; Ray Luo
Journal:  Biophys Chem       Date:  2009-09-01       Impact factor: 2.352

5.  Insight into a novel p53 single point mutation (G389E) by Molecular Dynamics Simulations.

Authors:  Davide Pirolli; Cristiana Carelli Alinovi; Ettore Capoluongo; Maria Antonia Satta; Paola Concolino; Bruno Giardina; Maria Cristina De Rosa
Journal:  Int J Mol Sci       Date:  2010-12-30       Impact factor: 5.923

6.  Lysine120 interactions with p53 response elements can allosterically direct p53 organization.

Authors:  Yongping Pan; Ruth Nussinov
Journal:  PLoS Comput Biol       Date:  2010-08-05       Impact factor: 4.475

7.  Conformational stability and dynamics of the cancer-associated isoform Δ133p53β are modulated by p53 peptides and p53-specific DNA.

Authors:  Jiangtao Lei; Ruxi Qi; Yegen Tang; Wenning Wang; Guanghong Wei; Ruth Nussinov; Buyong Ma
Journal:  FASEB J       Date:  2018-12-12       Impact factor: 5.834

8.  Mapping the structural and dynamical features of multiple p53 DNA binding domains: insights into loop 1 intrinsic dynamics.

Authors:  Suryani Lukman; David P Lane; Chandra S Verma
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

9.  A general and efficient strategy for generating the stable enzymes.

Authors:  Xiao-Fei Zhang; Guang-Yu Yang; Yong Zhang; Yuan Xie; Stephen G Withers; Yan Feng
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.